Abstract:Objective. Polycystic ovary syndrome (PCOS) is one of the prevalent gynecological endocrine disorders encountered in clinical practice. Women diagnosed with PCOS demonstrate increased ovarian responsiveness, rendering them more prone to ovarian hyperstimulation syndrome (OHSS) during controlled ovarian stimulation (COS) procedures. The current study aimed at investigating whether CCL25/CCR9 plays a role in the pathological process of high ovarian response (HOR) during COS procedures. Design. Single‐center retrospective cohort study. Patients. A total of 200 PCOS patients who received a fixed regimen of gonadotropin‐releasing hormone (GnRH) antagonist were enrolled in this study. The cohort comprised 118 patients exhibiting HOR and 82 patients demonstrating a normal ovarian response (NOR). Results. The age and body mass index (BMI) variances across the two groups did not differ significantly. Similarly, the two groups observed no statistically significant differences in the baseline levels of luteinizing hormone (LH), progesterone (P), estradiol (E 2 ), basal prolactin (PRL), and testosterone (T). Compared to the NOR group, HOR patients exhibit markedly elevated levels of anti‐Müllerian hormone (AMH), antral follicle count (AFC), basal follicle‐stimulating hormone (FSH), and HOMA‐IR (all p < 0.05). Conversely, no statistically significant differences were observed between the two groups with respect to COS parameters, encompassing initial gonadotropin (Gn) dose, stimulation duration, and total Gn dose. During COS, the number of oocytes with diameter ≥14 mm, the levels of E 2 on the HCG day, and the number of retrieved oocytes were significantly higher in the HOR group than in the NOR group (all p < 0.001). Additionally, the levels of CCL25/CCR9, matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs), TNF‐α, and IL‐6 were significantly higher in the FF of the HOR group than in the NOR group (all p < 0. 001), while the variance in IL‐1β levels between the two cohorts did not reach statistical significance. The relevance analysis results indicated that the levels of CCL25/CCR9 in the FF of the HOR group are positively correlated with the number of retrieved oocytes and oocytes with diameters ≥14 mm during COS, AMH levels, and AFC. Concurrently, the CCL25 levels in the FF of the HOR group were positively correlated with HOMA‐IR. Multivariable linear regression analysis revealed that the elevated AFC and HOMA‐IR independently increase the CCL25 levels. Conclusion. The CCL25/CCR9 levels in FF are positively correlated with the clinical indicators of HOR, suggesting that CCL25/CCR9 may play a role in the pathogenesis of HOR in patients with PCOS.

[Follicle-Stimulating Hormone Receptor Levels in Relation to Ovarian Cycling Response from Gonadotropin Hormone Stimulation]

Poor Ovarian Response To Gonadotropin Stimulation Is Associated With Low Expression Of Follicle-Stimulating Hormone Receptor In Granulosa Cells

[Relationship Between Follicular Development and Insulin Like Growth Factor I Receptor in Stimulated Cycles].

[Women with Poor Response to Ovarian Stimulation Have Increased Follicular Bone Morphogenetic Protein-15 Levels].

Investigation on the Relationship among Follicular Development and Insulin-Like Growth Factor-I and Its Receptor Mrna During Ovulation Stimulation Period

Expression of Gonadotrophin Receptor and Influencing Factors among Different Ovarian Reserve Patients

Ovarian Leukocyte Distribution and Cytokine/chemokine Mrna Expression in Follicular Fluid Cells in Women with Polycystic Ovary Syndrome.

Age and Expression of Follicle-stimulating Hormone Receptor in Granulosa Cells

The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles

The Relationship Between Serum Delta FSH Level and Ovarian Response in IVF/ICSI Cycles

Elevated Follicular Cortisone Level is a Negative Predictor of Clinical Pregnancy in Women Undergoing Fresh Embryo Transfer

[Correlation Between Follicular Fluid Srage Level and Ovarian Responsiveness in Non-Pcos Patients Undergoing Controlled Ovarian Hyperstimulation].

Relationship between CCL25/CCR9 Levels in Follicular Fluid and High Ovarian Response in Patients with Polycystic Ovary Syndrome

Factors Influencing Ovarian Response during In Vitro Fertilization and Embryo Transfer

A Dose-Response Study on Functional and Transcriptomic Effects of FSH on Ex Vivo Mouse Folliculogenesis

Effect of Exogenous Gonadotropin on the Transcriptome of Human Granulosa Cells and Follicular Fluid Hormone Profiles.

FSH isomer and ovarian response

The predictive value of the serum follicle-stimulating hormone to luteinizing hormone ratio affter putuitary down-regulation in IVF

Dose-response functional and transcriptomic effects of follicle-stimulating hormone on mouse folliculogenesis

[Impact of High Response of Ovary to Gonadotropin Stimulation on the Outcome of in Vitro Fertilization and Embryo Transfer or Intracytoplasmic Sperm Injection].

The FSHR G‐29A Variant is Not Associated with the Ovarian Response to Exogenous FSH Stimulation